Crohn Disease
Patent Issued Related to Prometheus Proprietary Test CBir1 Antigen Test Included in Diagnostic for Inflammatory Bowel Disease
Published in Lab Business Week, September 7th, 2008
Prometheus Laboratories Inc. announced the issuance of U.S. Patent No. 7,361,733, "Compositions and Methods for the Therapy and Diagnosis of Inflammatory Bowel Disease" which protects a flagellin peptide useful in the detection of antibodies to the flagellin CBir1, or anti-CBir1, for determining the presence of inflammatory bowel disease (IBD). This proprietary technology is used in the Company's PROMETHEUS(R) IBD Serology 7 test and its recently launched PROMETHEUS(R) IBS Diagnostic test. Prometheus has exclusive rights to this technology under an agreement with Corixa Corporation.
The patent provides a means of detecting the presence and levels of CBir1 antibodies in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2008-09-07)
More Articles from Lab Business Week
- BioNeutral Laboratories Corporation
BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana - CerMet Lab Company
SAE Test Confirms Fuel Economy Improvements with Cost Effective Ceramic Nano-Particle Conditioner - Drug Resistance
BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World - Enzyme Research
Research from Wolfson Wellcome Biomedical Laboratories, Zoology Department yields new data on enzyme research - Immunization
GeoVax Appoints Mr. Peter M. Tsolinas to Its Board of Directors - Pharmacology
New pharmacology study findings have been reported from Abbott Laboratories - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
